Clearance Summary
RX-1 Sleep received FDA 510(k) clearance under submission number K253148, sponsored by Vivaquant, Inc. Dba Rhythm Express. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2026-06-22.
- Submission: K253148
- Applicant / Sponsor: Vivaquant, Inc. Dba Rhythm Express
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.2375
- Decision date: 2026-06-22
Classification & Regulation
This clearance is catalogued under FDA product code MNR and 21 CFR 868.2375, within the Anesthesiology review panel as a Class II device.